![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RNF103 |
Gene summary for RNF103 |
![]() |
Gene information | Species | Human | Gene symbol | RNF103 | Gene ID | 7844 |
Gene name | ring finger protein 103 | |
Gene Alias | HKF-1 | |
Cytomap | 2p11.2 | |
Gene Type | protein-coding | GO ID | GO:0006464 | UniProtAcc | O00237 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
7844 | RNF103 | HCC1_Meng | Human | Liver | HCC | 3.97e-55 | 9.15e-03 | 0.0246 |
7844 | RNF103 | HCC2_Meng | Human | Liver | HCC | 4.91e-41 | 2.84e-01 | 0.0107 |
7844 | RNF103 | cirrhotic2 | Human | Liver | Cirrhotic | 1.82e-02 | 5.34e-02 | 0.0201 |
7844 | RNF103 | HCC1 | Human | Liver | HCC | 1.45e-02 | 2.72e+00 | 0.5336 |
7844 | RNF103 | HCC2 | Human | Liver | HCC | 6.53e-08 | 2.33e+00 | 0.5341 |
7844 | RNF103 | Pt13.b | Human | Liver | HCC | 1.41e-02 | -5.13e-02 | 0.0251 |
7844 | RNF103 | S015 | Human | Liver | HCC | 4.63e-02 | 2.85e-01 | 0.2375 |
7844 | RNF103 | S027 | Human | Liver | HCC | 4.30e-02 | 5.06e-01 | 0.2446 |
7844 | RNF103 | S028 | Human | Liver | HCC | 2.19e-06 | 4.76e-01 | 0.2503 |
7844 | RNF103 | S029 | Human | Liver | HCC | 3.04e-05 | 5.39e-01 | 0.2581 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Liver | ![]() | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease | ||
Prostate | ![]() | BPH: Benign Prostatic Hyperplasia |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:001049812 | Liver | Cirrhotic | proteasomal protein catabolic process | 216/4634 | 490/18723 | 2.52e-21 | 9.29e-19 | 216 |
GO:00349767 | Liver | Cirrhotic | response to endoplasmic reticulum stress | 130/4634 | 256/18723 | 1.72e-19 | 3.86e-17 | 130 |
GO:004316112 | Liver | Cirrhotic | proteasome-mediated ubiquitin-dependent protein catabolic process | 184/4634 | 412/18723 | 4.52e-19 | 8.85e-17 | 184 |
GO:0030433 | Liver | Cirrhotic | ubiquitin-dependent ERAD pathway | 45/4634 | 85/18723 | 2.19e-08 | 7.75e-07 | 45 |
GO:00365032 | Liver | Cirrhotic | ERAD pathway | 53/4634 | 107/18723 | 2.58e-08 | 8.89e-07 | 53 |
GO:00065171 | Liver | Cirrhotic | protein deglycosylation | 14/4634 | 26/18723 | 1.37e-03 | 9.14e-03 | 14 |
GO:00365071 | Liver | Cirrhotic | protein demannosylation | 10/4634 | 18/18723 | 5.00e-03 | 2.59e-02 | 10 |
GO:00365081 | Liver | Cirrhotic | protein alpha-1,2-demannosylation | 10/4634 | 18/18723 | 5.00e-03 | 2.59e-02 | 10 |
GO:001049822 | Liver | HCC | proteasomal protein catabolic process | 351/7958 | 490/18723 | 6.92e-40 | 1.46e-36 | 351 |
GO:004316122 | Liver | HCC | proteasome-mediated ubiquitin-dependent protein catabolic process | 299/7958 | 412/18723 | 7.82e-36 | 8.27e-33 | 299 |
GO:003497612 | Liver | HCC | response to endoplasmic reticulum stress | 189/7958 | 256/18723 | 1.43e-24 | 4.06e-22 | 189 |
GO:003650311 | Liver | HCC | ERAD pathway | 88/7958 | 107/18723 | 2.87e-17 | 2.85e-15 | 88 |
GO:00304331 | Liver | HCC | ubiquitin-dependent ERAD pathway | 72/7958 | 85/18723 | 9.78e-16 | 7.47e-14 | 72 |
GO:00065172 | Liver | HCC | protein deglycosylation | 22/7958 | 26/18723 | 1.23e-05 | 1.39e-04 | 22 |
GO:00365072 | Liver | HCC | protein demannosylation | 15/7958 | 18/18723 | 4.74e-04 | 3.12e-03 | 15 |
GO:00365082 | Liver | HCC | protein alpha-1,2-demannosylation | 15/7958 | 18/18723 | 4.74e-04 | 3.12e-03 | 15 |
GO:1904380 | Liver | HCC | endoplasmic reticulum mannose trimming | 13/7958 | 15/18723 | 5.67e-04 | 3.61e-03 | 13 |
GO:0009100 | Liver | HCC | glycoprotein metabolic process | 193/7958 | 387/18723 | 1.89e-03 | 9.62e-03 | 193 |
GO:001049818 | Prostate | BPH | proteasomal protein catabolic process | 153/3107 | 490/18723 | 4.13e-16 | 7.51e-14 | 153 |
GO:003497618 | Prostate | BPH | response to endoplasmic reticulum stress | 95/3107 | 256/18723 | 1.54e-15 | 2.52e-13 | 95 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RNF103 | SNV | Missense_Mutation | c.841N>A | p.Gly281Ser | p.G281S | O00237 | protein_coding | deleterious(0.01) | benign(0.287) | TCGA-38-4632-01 | Lung | lung adenocarcinoma | Male | <65 | III/IV | Chemotherapy | gemcitabine | PD | |
RNF103 | SNV | Missense_Mutation | c.430N>T | p.Val144Leu | p.V144L | O00237 | protein_coding | tolerated(0.2) | probably_damaging(0.956) | TCGA-55-7724-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
RNF103 | SNV | Missense_Mutation | rs367817642 | c.1475N>A | p.Arg492His | p.R492H | O00237 | protein_coding | tolerated(0.1) | benign(0.096) | TCGA-62-A46O-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
RNF103 | SNV | Missense_Mutation | novel | c.73N>G | p.Ile25Val | p.I25V | O00237 | protein_coding | tolerated(1) | benign(0) | TCGA-78-7539-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Chemotherapy | cisplatin | PD |
RNF103 | SNV | Missense_Mutation | c.1415C>T | p.Ser472Phe | p.S472F | O00237 | protein_coding | deleterious(0.01) | probably_damaging(0.991) | TCGA-18-3409-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
RNF103 | SNV | Missense_Mutation | c.1196C>A | p.Thr399Lys | p.T399K | O00237 | protein_coding | deleterious(0) | benign(0.162) | TCGA-18-4083-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | SD | |
RNF103 | SNV | Missense_Mutation | novel | c.1075N>G | p.Thr359Ala | p.T359A | O00237 | protein_coding | tolerated(0.36) | probably_damaging(0.97) | TCGA-39-5034-01 | Lung | lung squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
RNF103 | SNV | Missense_Mutation | novel | c.2054N>G | p.Ser685Cys | p.S685C | O00237 | protein_coding | deleterious_low_confidence(0) | benign(0.339) | TCGA-56-8624-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Chemotherapy | carboplatin | CR |
RNF103 | SNV | Missense_Mutation | novel | c.1545N>T | p.Trp515Cys | p.W515C | O00237 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-77-8009-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
RNF103 | SNV | Missense_Mutation | novel | c.831G>C | p.Met277Ile | p.M277I | O00237 | protein_coding | tolerated(0.43) | benign(0) | TCGA-CQ-6220-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |